Press Release from the Competition Council regarding the economic concentration project concerning the joint takeover of the company “Cardio Plus SARL” by Messrs. Abdallah Badaa, Soufiane Badaa, Abderrahim El Kanbi, and Karim Dakhch, through the acquisition of 49% of the share capital and related voting rights

In accordance with Article 13 of Law No. 104-12 on freedom of prices and competition and Article 10 of Decree No. 2-14-652 issued for its implementation, as amended and supplemented, the Competition Council makes available to the public the “operation summary” below, containing the information provided by the parties.

This information has been prepared by the notifying parties, who are solely responsible for it. Any inaccurate or distorted information contained therein does not in any way prejudge the Competition Council’s position on the proposed operation.

The publication of this press release does not attest to the completeness of the file provided for in Article 9 of Decree No. 2-14-652 issued for the implementation of Law No. 104-12 on freedom of prices and competition, as amended and supplemented.

Names of the companies and groups involved:

• The target: “Cardio Plus SARL”.

Nature of the operation

• Joint takeover.

Economic sector concerned

• Import and distribution of medical devices.

Deadline for interested third parties to submit their observations

• 10 days from the date of publication of this press release, i.e. April 15, 2024.

NON-CONFIDENTIAL SUMMARY OF THE OPERATION PROVIDED BY THE PARTIES

The Competition Council has received notification of an economic concentration project, whereby Messrs. Abdallah Badaa and Soufiane Badaa intend to acquire control of the company “Cardio Plus SARL” jointly with the original partners of the company, Messrs. Abderrahim El Kanbi and Karim Dakhch, through the acquisition of 49% of the share capital and related voting rights of said company.

The company “Cardio Plus SARL” specializes in the import and distribution of medical devices, primarily for the diagnosis and/or treatment of certain pathologies of the cardiovascular and neurologic/neurovascular systems.

The acquirers, Messrs. Abdallah Badaa and Soufiane Badaa, hold interests in companies active in sectors such as industry and distribution of consumer products.

The original partners, Messrs. Abderrahim El Kanbi and Karim Dakhch, currently hold 75% of the share capital and voting rights of the company “Cardio Plus SARL”.

Done in Rabat on April 4, 2024